Clicky

Fennec Pharmaceuticals Inc.(FENC) News

Date Title
Mar 11 Fennec Pharmaceuticals Inc (FENC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Mar 11 Q4 2024 Fennec Pharmaceuticals Inc Earnings Call
Mar 10 Wedbush Reviews Fennec Pharmaceuticals' Q4
Mar 10 Investing in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago would have delivered you a 38% gain
Mar 10 Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
Oct 1 The past three years for Fennec Pharmaceuticals (NASDAQ:FENC) investors has not been profitable
Sep 5 Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 15 Fennec Pharmaceuticals Second Quarter 2024 Earnings: Misses Expectations
Aug 14 Q2 2024 Fennec Pharmaceuticals Inc Earnings Call
Aug 13 Fennec Q2 Loss Stays Constant as Revenue More Than Doubles, Appoints Jeffrey Hackman as CEO
Aug 13 Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Jun 25 Fennec Announces Results of Annual Meeting
May 14 Fennec Pharmaceuticals Inc.'s (NASDAQ:FENC) largest shareholders are individual investors who were rewarded as market cap surged US$25m last week
May 14 Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
May 7 Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
Apr 9 Those who invested in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago are up 136%
Apr 5 Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)
Mar 27 Chief Financial Officer Robert Andrade Sells 13,975 Shares of Fennec Pharmaceuticals Inc (FENC)
Mar 26 Chief Financial Officer Robert Andrade Sells Shares of Fennec Pharmaceuticals Inc (FENC)
Mar 22 Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript